Short Interest in Advanced Biomed Inc. (NASDAQ:ADVB) Drops By 34.7%

Advanced Biomed Inc. (NASDAQ:ADVB) was the recipient of a significant drop in short interest in August. As of August 14th, there was short interest totaling 37,364 shares, a drop of 34.7% from the July 30th total of 57,213 shares. Based on an average daily trading volume, of 231,612 shares, the days-to-cover ratio is presently 0.2 days. Approximately 3.1% of the company’s shares are short sold.

Advanced Biomed Stock Up 12.0%

Shares of Advanced Biomed stock traded up $1.13 during mid-day trading on Tuesday, hitting $10.58. The stock had a trading volume of 281,463 shares, compared to its average volume of 885,909. The firm has a 50-day moving average of $7.77 and a two-hundred day moving average of $5.85. Advanced Biomed has a 12-month low of $3.61 and a 12-month high of $24.23. The firm has a market cap of $17.46 million, a P/E ratio of 2.20 and a beta of -0.41.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Wall Street Zen upgraded Advanced Biomed to a “hold” rating in a report on Saturday, August 22nd. Weiss Ratings upgraded Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 23rd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.